Vascular protection by chloroquine during brain tumor therapy with Tf- CRM107

Cancer Research

Volumn 60, Issue 2, 2000, Pages 230-234

  Hagihara, Naoshi ^a   Walbridge, Stuart ^a   Olson, Alan W ^b   Oldfield, Edward H ^a   Youle, Richard J ^a,c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Biochemistry Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DIPHTHERIA TOXIN; PROTECTIVE AGENT; TF CRM 107; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN TUMOR; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PETECHIA; PRIORITY JOURNAL; RAT; VEIN THROMBOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; GLIOSARCOMA; HUMANS; IMMUNOTOXINS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; RATS; RATS, INBRED F344; TRANSFERRIN; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0034650742     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Johnson, V. G., Wilson, D., Greenfield, L., and Youle, R. J. The role of the diphtheria toxin receptor in cytosol translocation. J. Biol Chem., 263: 1295-1300, 1988.
2. Greenfield, L., Johnson, V. G., and Youle, R. J. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity. Science (Washington DC), 238: 536-539, 1987.
3. Laske, D. W., Ilercil, O., Akbasak, A., Youle, R. J., and Oldfield, E. H. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. J. Neurosurg., 80: 520-526, 1994.
4. Laske, D. W., Youle, R. J., and Oldfield, E. H. Tumor regression with regional distribution of the targeted toxin Tf-CRM107 in patients with malignant brain tumors. Nat. Med., 3: 1362-1368, 1997.
5. Bobo, R. H., Laske, D. W., Akbasak, A., Morrison, P. F., Dedrick, R. L., and Oldfield, E. H. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. USA, 91: 2076-2080, 1994.
6. Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., and Mason, D. Y. Transferrin receptor on endothelium of brain capillaries. Nature (Lond.), 312: 162-163, 1984.
7. Kim, K., and Groman, N. B. In vitro inhibition of diphtheria toxin action by ammonium salts and amines. J. Bacteriol., 90: 1552-1556, 1965.
8. Sandvig, K., and Olsnes, S. Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule. J. Biol. Chem., 256: 9068-9076, 1981.
9. Donovan, J. J., Simon. M. I., Draper, R. K., and Montal, M. Diphtheria toxin forms transmembrane channels in planar lipid bilayers. Proc. Natl. Acad. Sci. USA, 78: 172-176, 1981.
10. Sandvig, K., and Olsnes, S. Diphtheria toxin entry into cells is facilitated by low pH. J. Cell Biol., 87: 828-832, 1980.
11. Draper, R. K., and Simon, M. I. The entry of diphtheria toxin into the mammalian cell cytoplasm: evidence for lysosomal involvement. J. Cell Biol., 87: 849-854, 1980.
12. Leppla, S., Dorland, R. B., and Middlebrook, J. L. Inhibition of diphtheria toxin degradation and cytotoxic action by chloroquine. J. Biol. Chem., 255: 2247-2250, 1980.
13. Agarwal, S. C., and Pryce. D. M. Experimental diphtheritic paralysis in rats. J. Path. Bact., 78: 171-177, 1959.
14. Eisenberg, D., Schwarz, E., Komaromy, M., and Wall, R. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol., 179: 125-142, 1984.
15. Oh, K. J., Zhan, H., Cui, C., Hideg, K., Collier, R. J., and Hubbell, W. L. Organization of diphtheria toxin T domain in bilayers: a site-directed spin labeling study. Science (Washington DC), 273: 810-812, 1996.
16. Seelig, A., Gottschlich, R., and Devant, R. M. A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc. Natl. Acad. Sci. USA, 91: 68-72, 1994.
17. Yamada, K., Ushio, Y., Hayakawa, T., Kato, A., Yamada, N., and Mogami, H. Quantitative autoradiographic measurements of blood-brair barrier permeability in the rat glioma model. J. Neurosurg., 57: 394-398, 1982.
18. Chamberlain, M. C., Murovic, J. A., and Levin, V. A. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology, 38: 1371-1374, 1988.
19. Gustafsson, L. L., Walker, O., Alvan, G., Beermann, B., Estevez., F., Gleisner, L., Lindstrom, B., and Sjoqvist, F. Disposition of chloroquine in man after single intravenous and oral doses. Br. J. Clin. Pharmacol., 15: 471-479, 1983.
20. Aderounmu, A. F., Salako, L. A., Lindstrom, B., Walker, O., and Ekman, L. Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br. J. Clin. Pharmacol., 22: 559-564, 1986.
21. Scherer, H. J. The forms of growth in gliomas and the practical significance. Brain, 63: 1-35, 1940.
22. Greene, G. M., Hitchon, P. W., Schelper, R. L., Yuh, W., and Dyste, G. N. Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J. Neurosurg., 71: 494-497, 1989.
23. Kelly, P. J., Daumas-Duport, C., Kispert, D. B., Kall, B. A., Scheithauer, B. W., and Illig, J. J. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J. Neurosurg., 66: 865-874, 1987.